POSACONAZOLE AS PRIMARY PROPHYLAXIS REDUCES INVASIVE FUNGAL INFECTIONS IN AML PATIENTS: A SINGLE CENTRE MATCHED PAIRED ANALYSIS

被引：0
|
作者：
Minetto, P. [1 ]
Guolo, F. [1 ]
Pastori, G. [1 ]
Giannoni, L. [1 ]
Guardo, D. [1 ]
Avenoso, D. [1 ]
Clavio, M. [1 ]
Miglino, M. [1 ]
Lemoli, R. M. [1 ]
Gobbi, M. [1 ]
机构：
[1] Univ Genoa, Chair Hematol, Dept Internal Med DiMI, IRCSS AOU San Martino IST, Genoa, Italy
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1813
引用
收藏
页码：717 / 718
页数：2
相关论文
共 50 条
  • [1] POSACONAZOLE AS PRIMARY PROPHYLAXIS REDUCES INVASIVE FUNGAL INFECTIONS IN AML PATIENTS: A SINGLE CENTRE MATCHED PAIRED ANALYSIS
    Guolo, F.
    Minetto, P.
    Pastori, G.
    Giannoni, L.
    Guardo, D.
    Ballerini, F.
    Miglino, M.
    Lemoli, R. M.
    Clavio, M.
    Gobbi, M.
    HAEMATOLOGICA, 2015, 100 : 72 - 72
  • [2] POSACONAZOLE IN PROPHYLAXIS OF FUNGAL INFECTIONS IN NEUTROPENIC PATIENTS A SINGLE CENTRE EXPERIENCE
    Zappone, E.
    Nardelli, S.
    Coppetelll, U.
    La Barbera, E. Ortu
    Centra, A.
    Ciabatta, C.
    Ciccone, F.
    Potente, G.
    De Blasio, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 360 - 361
  • [3] Prophylaxis of Invasive Fungal Infections: A Review of the Use of Posaconazole
    Collins, Curtis D.
    Smith, Jeannina A.
    Kaul, Daniel R.
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 1399 - 1408
  • [4] Single Arm, Single Centre Prospective Study to Assess the Effect of Therapeutic Drug Monitoring (TDM) Based Dosage Adjustment of Posaconazole on the Incidence of Invasive Fungal Infections (IFIs) in AML Patients on Induction Chemotherapy on Posaconazole Prophylaxis
    Sengar, Manju
    Boppana, Mounika
    Jain, Hasmukh
    Gota, Vikram
    Bagal, Bhausaheb
    Gokarn, Anant
    Gujrar, Murari
    Ambotkar, Madhavi
    BLOOD, 2019, 134
  • [5] Posaconazole - A review of its use in the prophylaxis of invasive fungal infections
    Frampton, James E.
    Scott, Lesley J.
    DRUGS, 2008, 68 (07) : 993 - 1016
  • [6] Posaconazole's impact on prophylaxis and treatment of invasive fungal infections: an update
    Smith, Winter J.
    Drew, Richard H.
    Perfect, John R.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2009, 7 (02) : 165 - 181
  • [7] Posaconazole demonstrates efficacy for prophylaxis of fungal infections in certain patients
    不详
    FORMULARY, 2007, 42 (03) : 184 - +
  • [8] Posaconazole in prophylaxis and treatment of invasive fungal infections: a pharmacokinetic, pharmacodynamic and clinical evaluation
    Van Daele, Ruth
    Spriet, Isabel
    Maertens, Johan
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2020, 16 (07) : 539 - 550
  • [9] COST-EFFECTIVENESS OF POSACONAZOLE IN THE PROPHYLAXIS OF INVASIVE FUNGAL INFECTIONS IN THE FRENCH SETTING
    Lafuma, A. L.
    Michallet, M.
    Herbrecht, R.
    Ribaud, P.
    Dupont, J. P.
    Gangneux, J. P.
    Moreau, P.
    Berger, P.
    O'Sullivan, A. K.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 321 - 322
  • [10] INDICATIVE BUDGET IMPACT OF POSACONAZOLE VERSUS FLUCONAZOLE IN INVASIVE FUNGAL INFECTION PROPHYLAXIS IN ADULT PATIENTS WITH AML/MDS
    Ahir, H. B.
    Taymor, E.
    Sung, A.
    Brese, B.
    Mayes, A.
    VALUE IN HEALTH, 2017, 20 (09) : A783 - A784
12345